ReviewCurrent osteoporosis reports2026
Health-related Quality of Life After Vertebral Augmentation for Osteoporotic Vertebral Compression Fractures.
Review in Current osteoporosis reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purpose of reviewHealth-related quality of life (HRQOL) in patients with osteoporotic vertebral compression fractures (OVCFs) varies significantly. This review summarizes the mechanisms of HRQOL impairment and evaluates the clinical evidence for vertebral augmentation (VA) procedures, specifically percutaneous vertebroplasty (PV), balloon kyphoplasty (BKP), and third-generation percutaneous vertebral augmentation systems (TVA). Additionally, we identify key factors influencing postoperative HRQOL recovery. RECENT
findingsOVCFs severely impair physical function and psychosocial well-being, increasing mortality risk by approximately 22%. While VA effectively alleviates pain and restores vertebral height, current evidence is largely limited to paired comparisons, and 8% to 40% of patients report persistent or recurrent postoperative pain. Crucially, few studies systematically compare HRQOL across the three primary VA techniques. Furthermore, significant methodological heterogeneity in surgical protocols and assessment tools continues to hinder the comparability of long-term functional outcomes. This review comprehensively examines the disparities in HRQOL recovery following VA for OVCFs and identifies critical research gaps. Further studies are warranted to elucidate the mechanisms underlying these variations, enabling the development of targeted clinical interventions.
Indexed as
Identifiers
41910873What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.